|
EP0006735B1
(en)
|
1978-06-28 |
1983-06-15 |
Beecham Group Plc |
Secondary amines, their preparation, pharmaceutical compositions containing them and their use
|
|
DE3061334D1
(en)
|
1979-06-16 |
1983-01-20 |
Beecham Group Plc |
Ethanamine derivatives, their preparation and use in pharmaceutical compositions
|
|
DE3061205D1
(en)
|
1979-06-16 |
1983-01-05 |
Beecham Group Plc |
Secondary amines, their preparation and use in pharmaceutical compositions
|
|
ES8800842A1
(es)
|
1985-03-01 |
1987-12-01 |
Beecham Group Plc |
Un procedimiento para preparar una formulacion veterinariamente aceptable de ariletanolaminas promotora del crecimiento.
|
|
GB8528633D0
(en)
|
1985-11-21 |
1985-12-24 |
Beecham Group Plc |
Compounds
|
|
IT1204416B
(it)
|
1986-06-27 |
1989-03-01 |
Midy Spa |
Medicamenti a base di analoghi di feniletanolammine per il trattamento di disturbi gastro-intestinali ed uterini
|
|
GB8801306D0
(en)
|
1988-01-21 |
1988-02-17 |
Ici Plc |
Chemical compounds
|
|
DE69028877T2
(de)
|
1989-06-13 |
1997-02-27 |
Sanofi Sa |
Verwendung von Phenylethanolaminen zur Herstellung von Medikamenten gegen Augenleiden
|
|
GB8925032D0
(en)
|
1989-11-06 |
1989-12-28 |
Ici Plc |
Chemical compounds
|
|
US5061727A
(en)
|
1990-05-04 |
1991-10-29 |
American Cyanamid Company |
Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
|
|
ATE185564T1
(de)
|
1992-08-31 |
1999-10-15 |
Sankyo Co |
Oxazolidin-derivate mit antidiabetika und anti- fettleibigkeit-eigenschaften, ihre herstellung und therapeutische verwendung
|
|
US5578638A
(en)
|
1993-11-05 |
1996-11-26 |
American Cyanamid Company |
Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
|
|
US5776983A
(en)
|
1993-12-21 |
1998-07-07 |
Bristol-Myers Squibb Company |
Catecholamine surrogates useful as β3 agonists
|
|
IL113084A
(en)
|
1994-03-23 |
1999-01-26 |
Sankyo Co |
Thiazolidine and oxazolidine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
|
|
IL113410A
(en)
|
1994-04-26 |
1999-11-30 |
Merck & Co Inc |
Substituted sulfonamides having an asymmetric center and pharmaceutical compositions containing them
|
|
US5561142A
(en)
|
1994-04-26 |
1996-10-01 |
Merck & Co., Inc. |
Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
|
|
US5705515A
(en)
|
1994-04-26 |
1998-01-06 |
Merck & Co., Inc. |
Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity
|
|
NZ295749A
(en)
|
1994-11-29 |
1998-05-27 |
Dainippon Pharmaceutical Co |
Indole derivatives; preparation and medicaments for treating obesity and diabetes mellitus
|
|
US5541204A
(en)
|
1994-12-02 |
1996-07-30 |
Bristol-Myers Squibb Company |
Aryloxypropanolamine β 3 adrenergic agonists
|
|
KR19990045727A
(ko)
|
1995-09-21 |
1999-06-25 |
피터 지. 스트링거 |
선택적 β３ 아드레날린 효능제
|
|
ZA967892B
(en)
|
1995-09-21 |
1998-03-18 |
Lilly Co Eli |
Selective β3 adrenergic agonists.
|
|
CZ126598A3
(cs)
|
1995-10-26 |
1998-09-16 |
Mitsubishi-Tokyo Pharmaceuticals, Inc. |
Fenylethanolaminové sloučeniny, způsob jejich výroby a farmaceutické prostředky s jejich obsahem
|
|
CA2242351C
(en)
|
1996-01-10 |
2003-03-11 |
Asahi Kasei Kogyo Kabushiki Kaisha |
Novel tricyclic compounds and drug compositions containing the same
|
|
US5770615A
(en)
|
1996-04-04 |
1998-06-23 |
Bristol-Myers Squibb Company |
Catecholamine surrogates useful as β3 agonists
|
|
EP0801060A1
(en)
|
1996-04-09 |
1997-10-15 |
Pfizer Inc. |
Heterocyclic Beta-3 Adrenergenic Agonists
|
|
CA2257206A1
(en)
|
1996-06-07 |
1997-12-11 |
Gui-Bai Liang |
Oxadiazole benzenesulfonamides as selective .beta.3 agonists for the treatment of diabetes and obesity
|
|
EP0827746B1
(en)
|
1996-09-05 |
2002-04-03 |
Eli Lilly And Company |
Carbazole analogues as selective beta3 adrenergic agonists
|
|
KR20000070568A
(ko)
|
1997-01-28 |
2000-11-25 |
폴락 돈나 엘. |
당뇨병 및 비만 치료를 위한 β3 효능제로서의 티아졸 벤젠설폰아미드
|
|
US6172099B1
(en)
|
1997-07-03 |
2001-01-09 |
Asahi Kasei Kogyo Kabushiki Kaisha |
Tricyclic compounds having saturated rings and medicinal compositions containing the same
|
|
ES2398097T3
(es)
|
2000-07-13 |
2013-03-13 |
Eli Lilly And Company |
Agonistas adrenérgicos beta3
|
|
US6537994B2
(en)
|
2000-07-17 |
2003-03-25 |
Wyeth |
Heterocyclic β3 adrenergic receptor agonists
|
|
US20040242485A1
(en)
|
2003-05-30 |
2004-12-02 |
Takashi Kadowaki |
Compositions and methods for the amelioration of leptin resistance
|
|
US20130143797A1
(en)
|
2010-06-25 |
2013-06-06 |
Michael J. Tisdale |
Glycoproteins Having Lipid Mobilizing Properties an Therapeutic Uses Thereof
|
|
CN102764438A
(zh)
*
|
2012-01-30 |
2012-11-07 |
林曙光 |
β3肾上腺素受体激动剂的新用途
|